These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9673744)

  • 1. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).
    Poole PJ; Brodie SM; Stewart JM; Black PN
    Aust N Z J Med; 1998 Jun; 28(3):322-6. PubMed ID: 9673744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD.
    Poole PJ; Saini R; Brodie SM; Black PN
    Respir Med; 2005 Mar; 99(3):372-6. PubMed ID: 15733514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular nebulised terbutaline in chronic obstructive airways disease: dose-response studies fail to detect tolerance.
    Teale C; Pearson SB
    Br J Clin Pharmacol; 1991 Jul; 32(1):111-4. PubMed ID: 1888629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domiciliary nebulized terbutaline in severe chronic airways obstruction.
    Hansen NC; May O
    Eur Respir J; 1990 Apr; 3(4):463-4. PubMed ID: 2365041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma.
    Goodacre S; Cohen J; Bradburn M; Stevens J; Gray A; Benger J; Coats T;
    Health Technol Assess; 2014 Apr; 18(22):1-168. PubMed ID: 24731521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD.
    Noseda A; Schmerber J; Prigogine T; Yernault JC
    Eur Respir J; 1992 Oct; 5(9):1043-53. PubMed ID: 1426213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
    Respir Med; 1993 Aug; 87(6):433-8. PubMed ID: 8105519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.
    Sutton PP; Gemmell HG; Innes N; Davidson J; Smith FW; Legge JS; Friend JA
    Thorax; 1988 Jan; 43(1):57-60. PubMed ID: 3353875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.
    Leung R; Hill P; Burdon J
    Thorax; 1996 Jun; 51(6):596-600. PubMed ID: 8693440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbutaline in COPD comparison between Turbuhaler and chlorofluorocarbon (CFC) inhaler.
    Formgren H; Sjökvist A; Ståhl E; Wirén JE
    Lung; 1994; 172(5):271-80. PubMed ID: 7934151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
    Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease.
    Masood AR; Reed JW; Thomas SH
    Thorax; 1995 Jun; 50(6):629-34. PubMed ID: 7638804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease.
    Campbell M; Eliraz A; Johansson G; Tornling G; Nihlén U; Bengtsson T; Rabe KF
    Respir Med; 2005 Dec; 99(12):1511-20. PubMed ID: 16199148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.